Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | GMNN | O75496 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4666972 | 0.81 | MAPT (0.49) | MAPTMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL2114866 | 0.79 | CDC25B (0.52) | CDC25BMAPTNR4A1NR4A2NR4A3 | |
| SCHEMBL27525529 | 0.78 | CDC25B (0.51) | CDC25BMAPTNR4A1NR4A2NR4A3 | |
| SCHEMBL7387704 | 0.78 | CTNNB1 (0.55) | MAPTKMT2AKDM4EALDH1A1TDP1 | |
| SCHEMBL8385259 | 0.77 | NR4A1 (0.56) | CDC25BMAPTNR4A1NR4A2NR4A3 | |
| SCHEMBL4573824 | 0.77 | KMT2A (0.59) | CDC25BMAPTNR4A1NR4A2NR4A3 | |
| SCHEMBL25384255 | 0.75 | CDC25B (0.51) | CDC25BNR4A1NR4A2NR4A3PTPN1 | |
| SCHEMBL30546550 | 0.75 | CDC25B (0.51) | CDC25BNR4A1NR4A2NR4A3PTPN1 | |
| SCHEMBL7654481 | 0.75 | TDP1 (0.52) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL7651877 | 0.75 | TDP1 (0.52) | MAPTMEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8008507-B2 | Fluorescent diketopyrrolopyrroles | BASF SE Ludwigshafen (DE) | 2011-08-30 | — | — | US | disclosed |
| EP-1817392-B1 | FLUORESCENT DIKETOPYRROLOPYRROLES | CIBA HOLDING INC (CH) | 2009-01-07 | — | — | EP | disclosed |
| US-20080217581-A1 | Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance | CIBA CORPORATION | 2008-09-11 | — | — | US | disclosed |
| EP-1817392-A1 | FLUORESCENT DIKETOPYRROLOPYRROLES | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006061343-A1 | FLUORESCENT DIKETOPYRROLOPYRROLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080217581-A1 | Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance | TYR, MC1R, IK | CDC25B 3094/4885MAPT 1123/4885NR4A1 2825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.